# Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

Study · id `cardio:ct-nct01035450` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01035450](<https://clinicaltrials.gov/study/NCT01035450>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01035450

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3206 participants.

## Technical summary

Registry record NCT01035450. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2014-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3206 participants (enrolled count; ClinicalTrials.gov record NCT01035450, source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01035450, source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)
- Primary completion: 2014-03 (actual) (ClinicalTrials.gov record NCT01035450, source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)
- Completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01035450, source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01035450, source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01035450-2015-12-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
- Acronym: RESET
- Condition: Coronary Artery Disease
- Intervention (Device): Everolimus-eluting stent
- Intervention (Device): Sirolimus-eluting stent
- Lead sponsor: Takeshi Morimoto
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Takeshi Morimoto (`cardio:org-takeshi-morimoto`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (`cardio:pubmed-24803436`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial (`cardio:pubmed-30947938`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study (`cardio:pubmed-37545171`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 306fceac8e41aefee2006b253a953bf8a0675306968140c7019bed4e7b0d4a56
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
